Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SSR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RABL6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEL1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMED3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIGP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR1908 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFIL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF103 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLE3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPARP-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
GRB14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6834 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREB3L4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR61 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIMP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WLS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBA5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on